customer service software
0

Global RNAI Technology Market

  • Published Date: 08 Jul 2018
  • Number of Pages: 191
  • Category: Healthcare and Medical
  • Country: Global
RNAI Technologyor RNA Interference is a process by which a particular gene is inhibited. This results in the related protein being no longer processed. Naturally this occurs for the regulation of certain genes or as defence against viruses. However, in research it is used to check the effect of absence of a gene on the whole organism or cell. TheRNAI Technology Market was valued at USAD XXX Billion in 2015 and is expected to reach USAD XXX Billion by 2020, at a CAGR of XX% between 2015 and 2020.
RNAi is a process in which a certain geneis regulated. It is an important pathway that is used by various organisms. People in thepharmaceutical and biotechnology world are taking an heightenedinterest in RNAi technology, as it is believed to substitute the existing recombinant technology in therapeutics and drug discovery.

Market Dynamics

The major factors boosting the market of RNAI Technology are as under:
1. One of the major drivers of the RNAI Technology market is the advent of metabolic and genetic disorders such as cancers coupled with the increased research in the field of RNA Therapeutics.
2. The increased application of molecular drug discovery technology in specially for diseases such as cancer has further given a boost to this market.

However, the major restraints to the growth of the RNAI Technology Market are as under:
1. RNA molecules are inherently unstable and immunogenic which poses a problem in research and drug delivery as targeted delivery of the RNA molecules to specified tissues is not possible. This is one of the major challenges which the RNAI market faces.
2. The high initial costs and dearth of skilled professionals and bioinformatics tool are also posing as a roadblock in the development of this market.
3. Stringent FDA regulations and other government regulation are also a hindrance to the growth of the market.

Market Segmentation

The RNAI Technology market is bifurcated on the basis of type of application, therapeutics, tools and region. The further bifurcations for the segments is represented below:
--> On the basis of Type of Application
o Drug Discovery and Development
o Therapeutics
o Drug Delivery
-> Nanoparticle Drug Delivery Technology
-> Pulmonary Drug Delivery Technology
-> Nucleic Acid Drug Delivery Technology
-> Aptamer Drug Delivery Technology
o Others
In this segment nanoparticle drug delivery is the largest sub-segment and aptamer drug delivery is the fastest growing sub-segment.

--> On the basis of Therapeutics
o Oncology
o Ocular Disorders
o Respiratory Disorders
o Liver Diseases
o Neuronal Disorders

--> On the basis of Tools
o Design/Software
o Delivery Based
o Monitoring
o Libraries

--> On the basis of Region
o North America
-> Canada
-> USA
o Europe
-> Germany
-> France
-> UK
o Asia Pacific
o Middle East and Africa

Geographic Analysis

Geographically the market is segmented into following different regions:North Americas, Europe, the Asia-Pacific, Latin America and Middle East and Africa. North America is the largest shareholder in market of RNAI. In North America USA is the major market followed by Canada. This is attributed to the increased application of RNAI in drug discovery and clinical diagnosis and also due to the expansion and presence of the major pharmaceutical and biological companies in the region. North America is followed by Europe in market dominance. In Europe Germany, UK, France are major contributors to the RNAI drug delivery market. However, Asia Pacific is expected to show the highest CAGR during the forecast period due to the rising presence and investments by major biotechnology companies in the region which is fuelling the research and development activities in the region and hence boosting the RNAI market.

Key Players

The key players who are driving the market of RNAI Technology and determine its future are: Affymetrix Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.),Marina Biotech Inc., Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.),Thermofisher Scientific Inc. (U.S.), Alnylam Pharmaceuticals Inc., Merck & Co. Inc., Isis Pharmaceuticals, Inc, Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Calondo Pharmaceuticals Inc., RXi Pharmaceuticals Corp., Quark Pharmaceuticals Inc., Silence Therapeutics plc,Tekmira Pharmaceuticals Corp., Tacere Therapeutics Inc.Agilent Technologies Inc. (U.S.), PhaseRx Inc., Sirnaomics Inc., and Traversa Therapeutics Inc..

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada


> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America


> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe


> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe


> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific


> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa



This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage

Publisher Name : Market Litmus

Vital Sign Monitors - Medical Devices Pipeline Assessment, 2019 GlobalDatas Medical Devices sector report, Vital Sign Monitors - Medical Devices Pipeline Assessment, 2019 provides an overview of Vital Sign Monitors currently

View Report

Clinical IT (Information Technology) Systems - Medical Devices Pipeline Assessment, 2019 GlobalDatas Medical Devices sector report, Clinical IT (Information Technology) Systems - Medical Devices Pipeline Assessment, 2019 provides an overview of

View Report

Multiparameter Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2019 GlobalDatas Medical Devices sector report, Multiparameter Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2019 provides an overview of Multiparameter Patient

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports